Health Care & Life Sciences » Biotechnology | NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc.
Stock Exchange NYSE
EPS
 $0.54
Market Cap
 $31.63 M
Shares Outstanding
 19.17 M
Public Float
 5.15 M

Profile

Address
2000 Powell Street
Emeryville California 94608
United States
Employees -
Website http://novabay.com
Updated 07/08/2019
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Financials

View All
Created with Highcharts 5.0.14NovaBay Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.16 04216 04215 19415 19418 97318 97313 15113 1517 4037 4036 5456 54520132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14NovaBay Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.3 4773 4771 0541 0544 3814 38111 89711 89718 23018 23012 50812 50820132014201520162017201805k10k15k20k

Mark M. Sieczkarek
Chairman, President & Chief Executive Officer
Yan Bin Liu
Non-Independent Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.